A Novel Platform Using RNA Signatures To Accelerate Antimicrobial Susceptibility Testing in Neisseria Gonorrhoeae
Overview
Authors
Affiliations
The rise of antimicrobial-resistant pathogens can be attributed to the lack of a rapid pathogen identification (ID) or antimicrobial susceptibility testing (AST), resulting in delayed therapeutic decisions at the point of care. Gonorrhea is usually empirically treated, with no AST results available before treatment, thus contributing to the rapid rise in drug resistance. Here, we present a rapid AST platform using RNA signatures for Transcriptome sequencing (RNA-seq) followed by bioinformatic tools was applied to explore potential markers in the transcriptome profile of upon minutes of azithromycin exposure. Validation of candidate markers using quantitative real-time PCR (qRT-PCR) showed that two markers ( [NGO1562] and ) can deliver accurate AST results across 14 tested isolates. Further validation of our susceptibility threshold in comparison to MIC across 64 more isolates confirmed the reliability of our platform. Our RNA markers combined with emerging molecular point-of-care systems has the potential to greatly accelerate both ID and AST to inform treatment.
Rapid Detection of MCR-Mediated Colistin Resistance in Escherichia coli.
Zhang H, Yu F, Lu X, Li Y, Peng D, Wang Z Microbiol Spectr. 2022; 10(3):e0092022.
PMID: 35616398 PMC: 9241874. DOI: 10.1128/spectrum.00920-22.
Hsieh K, Melendez J, Gaydos C, Wang T Lab Chip. 2022; 22(3):476-511.
PMID: 35048928 PMC: 9035340. DOI: 10.1039/d1lc00665g.
Melendez J, Chen F, Wang T Diagn Microbiol Infect Dis. 2021; 102(2):115590.
PMID: 34871932 PMC: 9241851. DOI: 10.1016/j.diagmicrobio.2021.115590.
Zhang H, Li Y, Jiang Y, Lu X, Li R, Peng D Microbiol Spectr. 2021; 9(2):e0064821.
PMID: 34704829 PMC: 8549723. DOI: 10.1128/Spectrum.00648-21.
Biographical Feature: Karen C. Carroll, M.D.
Munson E J Clin Microbiol. 2021; 59(8):e0065121.
PMID: 33853837 PMC: 8288278. DOI: 10.1128/JCM.00651-21.